These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24622783)

  • 1. Insulin resistance, neuroinflammation, and Alzheimer's disease.
    Najem D; Bamji-Mirza M; Chang N; Liu QY; Zhang W
    Rev Neurosci; 2014; 25(4):509-25. PubMed ID: 24622783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dysregulation in Alzheimer's disease.
    Bojarski L; Herms J; Kuznicki J
    Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies.
    Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2005 Jan; 109(1):25-31. PubMed ID: 15645264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer culprits: cellular crossroads and interplay.
    Claeysen S; Cochet M; Donneger R; Dumuis A; Bockaert J; Giannoni P
    Cell Signal; 2012 Sep; 24(9):1831-40. PubMed ID: 22627093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
    Koistinaho M; Koistinaho J
    Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?
    Wirz KT; Keitel S; Swaab DF; Verhaagen J; Bossers K
    J Alzheimers Dis; 2014; 38(4):719-40. PubMed ID: 24072070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Brain Insulin Resistance and Alzheimer's Molecular Changes by Western Diet.
    Mietelska-Porowska A; Domańska J; Want A; Więckowska-Gacek A; Chutorański D; Koperski M; Wojda U
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.